[Therapy of deep leg vein thrombosis. When is surgical therapy indicated?].
In spite of quite a few clinical trials the benefit of venous thrombectomy is seen controversially. The primary objectives of treating venous thrombosis are survival rate, prevention of pulmonary embolism and of postthrombotic syndrome. We report our experience with 47 patients who underwent venous thrombectomy. The mortality rate was 0%. We did not observe clinically relevant pulmonary embolism. After two years 90% of thrombectomised veins were patent. The mortality rates given in the literature of conservative treatment with heparin and following oral anticoagulation are 0.4 to 1.6%. Fibrinolysis shows mortality rates of 1 to 2.4, and thrombectomy of 3.8%, respectively. Venous thrombectomy is an effective treatment to prevent pulmonary embolism. In our own experience we saw no clinically significant pulmonary event. The danger of embolism rises with the proximity of the venous thrombus. Therefore those patients may have the greatest potential benefit from thrombectomy who present with a mobile inguinal thrombus or a thrombus in the iliac vein. So far there are no statistically sufficient data to support the indication of thrombectomy to prevent a postthrombotic syndrome.
Ockert
D
D
Klinik für Viszeral-, Thorax- und Gefässchirurgie, Medizinischen Fakultät Carl Gustav Carus, TU Dresden.
Schellong
S
S
Bergert
H
H
Scholz
A
A
Zimmermann
T
T
Nagel
M
M
Saeger
H D
HD
D000328:Adult; D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000209:etiology / Q000401:mortality; D011186:Postphlebitic Syndrome / Q000517:prevention & control; D011655:Pulmonary Embolism / Q000517:prevention & control; D015996:Survival Rate; D017131:Thrombectomy; D013924:Thrombophlebitis / Q000401:mortality / Q000601:surgery*